基因组H3K36突变通过改变基因组甲基化场景促进了瘤发生
Chao Lu1, Siddhant U Jain2, Dominik Hoelper2
1Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY 10065, USA.
概括
基因组H3突变 (H3K36M) 通过破坏甲基化模式,损害细胞分化并驱动肉瘤的形成. 这种机制在儿童癌症和人类不分化的瘤中被观察到.
科学领域:
- 分子生物学
- 癌症生物学
- 表观遗传学
背景情况:
- 儿童癌症经常表现出错误的H3基因突变.
- 这些基因突变所带来的致癌机制尚不清楚.
研究的目的:
- 研究H3K36M突变在介质细胞前代细胞中的功能后果.
- 阐明H3K36M驱动瘤发生的分子机制及其对人类瘤的相关性.
主要方法:
- 使用H3K36M突变模型的体内研究.
- 用于评估H3K36甲基转移酶活性的酶定量.
- 基因组甲基化模式 (H3K36me,H3K27me) 和多抑制复合体1 (PRC1) 分布的分析.
- 在人类未分化的肉瘤样本中识别H3K36M/I突变.
主要成果:
- 在体内,H3K36M突变会损害中酶原细胞的分化,并诱导不分化的肉瘤.
- H3K36M突变核细胞抑制H3K36甲基转移酶,模仿H3K36甲基转移酶耗尽或H3K36I突变的影响.
- H3K36甲基化的丧失导致H3K27甲基化的增加,PRC1的再分配,以及分化阻断基因的去抑制.
- 在人类不分化的瘤中发现了新的H3.1 K36M/ I突变.
结论:
- H3K36M突变通过破坏间酶分化的表观遗传调节来驱动肉瘤的发展.
- 这些发现揭示了一种新型的致癌机制,涉及基因组甲基化和PRC1活性的改变.
- 该研究确定H3 K36M/I突变是人类不分化瘤的潜在驱动因素,将临床前模型与人类疾病联系起来.
相关概念视频
Histone Variants at the Centromere
5.2K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.2K
Epigenetic Regulation
4.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.1K
Epigenetic Regulation
34.2K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Histone Modification
17.0K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
17.0K
Histone Modification
4.9K
4.9K
Spreading of Chromatin Modifications
9.9K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
9.9K


